Multimodal therapy for painful bladder syndrome/interstitial cystitis

Journal of Reproductive Medicine for the Obstetrician and Gynecologist

Volumn 51, Issue 3 SUPPL., 2006, Pages 253-260

  Dell, Jeffrey R ^a   Butrick, Charles W ^b  

^a Institute for Female Pelvic Medicine   (United States)

^b The Urogynecology Center   (United States)

Author keywords

Bladder diseases; Interstitial cystitis; Painful bladder syndrome; Pelvic pain

Indexed keywords

ACETYLSALICYLIC ACID; AMITRIPTYLINE; ANTIHISTAMINIC AGENT; BACLOFEN; BCG VACCINE; BOTULINUM TOXIN A; CAPSAICIN; CITRATE POTASSIUM; CYCLOBENZAPRINE; CYCLOSPORIN A; DIAZEPAM; ESTROGEN; GABAPENTIN; HYDROXYZINE; HYOSCYAMINE; IMMUNOSUPPRESSIVE AGENT; MUSCLE RELAXANT AGENT; NEUROLEPTIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; ORAL CONTRACEPTIVE AGENT; OXYBUTYNIN; PENTOSAN POLYSULFATE; PROSTAGLANDIN E1; RESINIFERATOXIN; SUPLATAST TOSYLATE; TIZANIDINE; TOPIRAMATE; TRICYCLIC ANTIDEPRESSANT AGENT; UNINDEXED DRUG; VANILLOID RECEPTOR; ANALGESIC AGENT; ANTIBIOTIC AGENT; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; BICARBONATE; CHOLINERGIC RECEPTOR BLOCKING AGENT; DIMETHYL SULFOXIDE; HEPARIN; LIDOCAINE; MONTELUKAST; OPIATE; PLACEBO; PREGABALIN; TOLTERODINE; DIAGNOSTIC AGENT;

ABSENCE OF SIDE EFFECTS; ALOPECIA; ANALGESIA; ARTICLE; BLADDER DISEASE; BLADDER RECONSTRUCTION; CLINICAL FEATURE; CLINICAL TRIAL; CYSTECTOMY; DIAGNOSTIC TEST; DIFFERENTIAL DIAGNOSIS; DRUG APPROVAL; DRUG EFFICACY; DRUG SAFETY; FEMALE; GASTROINTESTINAL SYMPTOM; HEADACHE; HUMAN; INTERSTITIAL CYSTITIS; LIVER DYSFUNCTION; PATIENT EDUCATION; PELVIS PAIN SYNDROME; POTASSIUM SENSITIVITY TEST; PRIORITY JOURNAL; QUALITY OF LIFE; SOCIAL SUPPORT; BEHAVIOR MODIFICATION; BLOOD CLOTTING DISORDER; CELL ACTIVATION; DIARRHEA; DIET THERAPY; DRUG DOSAGE FORM; DRUG INSTILLATION; EARLY DIAGNOSIS; EPIDURAL DRUG ADMINISTRATION; EXERCISE; HALITOSIS; LOW LEVEL LASER THERAPY; MAST CELL; NAUSEA; NERVE CELL; ODOR; PAINFUL BLADDER SYNDROME; PATIENT CARE; PELVIC PAIN AND URGENCY FREQUENCY SYMPTOM SCALE; PHYSIOTHERAPY; RARE DISEASE; RASH; RATING SCALE; RECTUM HEMORRHAGE; REVIEW; SCREENING; SKIN DISEASE; TASTE DISORDER; TREATMENT RESPONSE; UNSPECIFIED SIDE EFFECT; URETHRA DISEASE; URETHRAL PAIN; UROTHELIUM; XEROSTOMIA; INTRAVESICAL DRUG ADMINISTRATION; ULCER;

ADMINISTRATION, INTRAVESICAL; ANALGESICS, NON-NARCOTIC; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CLINICAL TRIALS; CYSTITIS, INTERSTITIAL; DIMETHYL SULFOXIDE; FEMALE; HUMANS; PELVIC PAIN; PENTOSAN SULFURIC POLYESTER; ULCER; URINARY BLADDER DISEASES;

EID: 33645775691     PISSN: 00247758     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Rovner E, Propert KJ, Brensinger C, et al: Treatments used in women with interstitial cystitis: The interstitial cystitis data base (ICDB) study experience: The Interstitial Cystitis Data Base Study Group. Urology 2000;56:940-945
2. Selo-Ojeme DO, Onwude JL: Interstitial cystitis. J Obstet Gynaecol 2004;24:216-225
3. Parsons CL: Current strategies for managing interstitial cystitis. Expert Opin Pharmacother 2004;5:287-293
4. Parsons CL: Evidence-based strategies for recognizing and managing IC. Contemp Urol 2003;February:22-35
5. Dell JR, Parsons CL: Multimodal therapy for interstitial cystitis. J Reprod Med 2004;49:243-252
6. Lukban JC, Parkin JV, Holzberg AS, et al: Interstitial cystitis and pelvic floor dysfunction: A comprehensive review. Pain Med 20012:60-71
7. Weiss J: Pelvic floor myofascial trigger points: Manual therapy for interstitial cystitis and the urgency-frequency syndrome. J Urol 2001;166:2226-2231
8. Oyama IA, Rejba A, Lukban JC, et al: Modified Thiele massage as therapeutic intervention for female patients with interstitial cystitis and high-tone pelvic floor dysfunction. Urology 2004;64:862-865
9. Parsons CL, Forrest J, Nickel JC, et al: Effect of pentosan polysulfate therapy on intravesical potassium sensitivity. Urology 2002;59:329-333
10. Kahn BS, Stanford EJ, Mishell DR Jr, et al: Management of patients with interstitial cystitis or chronic pelvic pain of bladder origin: A consensus report. Curr Med Res Opin 2005;21:509-516
11. Parsons CL, Benson G, Childs SJ, et al: A quantitatively controlled method to study prospectively interstitial cystitis and demonstrate the efficacy of pentosanpolysulfate. J Urol 1993;150:845-848
12. Nickel J, Barkin J, Forrest J, et al: Randomized, double-blind, dose-ranging study of pentosan polysulfate sodium for interstitial cystitis. J Urol 2001;165:67
13. Hanno PM: Analysis of long-term Elmiron therapy for interstitial cystitis. Urology 1997;49:93-99
14. Nickel JC, Forrest J, Barkin J, et al: Safety and efficacy of up to 900 mg/day polysulfate sodium (elmiron) in patients with interstitial cystitis. Urology 2001;57:122-123
15. Nickel JC, Barkin J, Forrest J, et al: Randomized, double-blind, dose-ranging study of pentosan polysulfate sodium for interstitial cystitis. Urology 2005;65:654-658
16. Chung M: Interstitial cystitis in persistent posthysterectomy chronic pelvic pain. J Soc Laparosc Surgeons 2004;8:329-333
17. Elmiron® 100 mg (pentosan polysulfate sodium): Prescribing information. Raritan, New Jersey, Ortho-McNeil Pharmaceutical, 2004
18. Sant GR, Propert KJ, Hanno PM, et al: A pilot clinical trial of oral pentosan polysulfate and oral hydroxyzine in patients with interstitial cystitis. J Urol 2003;170:810-815
19. Bouchelouche K, Kristensen B, Nordling J, et al. Increased urinary leukotriene E4 and eosinophil protein X excretion in patients with interstitial cystitis. J Urol 2001;166:2121-2125
20. van Ophoven A, Hertle L: Long term results of amitriptyline treatment for interstitial cystitis (abstr 312). J Urol 2005;173:86
21. van Ophoven A, Pokupic S, Heinecke A, et al: A prospective, randomized, placebo controlled, double-blind study of amitriptyline for the treatment of interstitial cystitis. J Urol 2004;172:533-536
22. Hansen HC: Interstitial cystitis and the potential role of gabapentin. South Med J 2000;93:238-242
23. Sasaki K, Smith CP, Chuang YC, et al: Oral gabapentin (neurontin) treatment of refractory genitourinary tract pain. Tech Urol 2001;7:47-19
24. Sukiennik A, Carr D, Bonney I, et al: The effect of short-term epidural local anesthetic blockade on urinary levels of substance P in interstitial cystitis. Anesth Analg 2004;98:846-850
25. Sant GR: Intravesical 50% dimethyl sulfoxide (Rimso-50) in treatment of interstitial cystitis. Urology 1987;29:17-21
26. Rossberger J, Fall M, Peeker R: Critical appraisal of dimethyl sulfoxide treatment for interstitial cystitis: Discomfort, side-effects and treatment outcome. Scand J Urol Nephrol 2005;39:73-77
27. Parsons CL: Successful downregulation of bladder sensory nerves with combination of heparin and alkalinized lidocaine in patients with interstitial cystitis. Urology 2005;65:45-18
28. Dell JR, Grochmal SA: Intravesical instillation therapy using pentosan polysulfate sodium in patients with interstitial cystitis. Poster presented at Global Congress of Gynecologic Endoscopy, 33rd Annual Meeting of the American Association of Gynecologic Laparoscopists, San Francisco, November 10-13, 2004
29. Yamada T, Murayama T, Andoh M: Adjuvant hydrodistension under epidural anesthesia for interstitial cystitis. Int J Urol 2003;10:463-468; discussion 469
30. Glemain P, Riviere C, Lenormand L, et al: Prolonged hydrodistention of the bladder for symptomatic treatment of interstitial cystitis: Efficacy at 6 months and 1 year. Eur Urol 2002;41:79-84
31. Bouchelouche K, Nordling J: Recent developments in the management of interstitial cystitis. Curr Opin Urol 2003;13:309-313
32. Comiter CV: Sacral neuromodulation for the symptomatic treatment of refractory interstitial cystitis: a prospective study. J Urol 2003;169:1369-1373
33. Vaze AA, Rackley RR, Murphy D, et al: Neuromodulation for interstitial cystitis (abstr 309). J Urol 2005;173:85
34. Chai TC, Zhang C, Warren JW, et al: Percutaneous sacral third nerve root neurostimulation improves symptoms and normalizes urinary HB-EGF levels and antiproliferative activity in patients with interstitial cystitis. Urology 2000;55:643-646
35. Mayer R, Propert KJ, Peters KM, et al: A randomized controlled trial of intravesical bacillus Calmette-Guerin for treatment of refractory interstitial cystitis. J Urol 2005;173:1186-1191
36. Chancellor MB, Yoshimura N: Treatment of interstitial cystitis. Urology 2004;63:85-92
37. Lazzeri M, Spinelli M, Beneforti P, et al: Intravesical infusion of resiniferatoxin by a temporary in situ drug delivery system to treat interstitial cystitis: A pilot study. Eur Urol 2004;45:98-102
38. Smith CP, Nishiguchi J, O'Leary M, et al: Single-institution experience in 110 patients with botulinum toxin A injection into bladder or urethra. Urology 2005;65:37-41
39. Kuo HC: Botulinum A toxin urethral injection for the treatment of lower urinary tract dysfunction. J Urol 2003;170:1908-1912
40. Chancellor MB, Smith CP: Pittsburgh experience with lower urinary tract botulinum toxin A injection. Curr Urol Rep 2005;6:235-236
41. Sairanen J, Forsell T, Ruutu M: Long-term outcome of patients with interstitial cystitis treated with low dose cyclosporine A. J Urol 2004;171:2138-2141